CEA |
|
Test Code |
524 |
Unit |
ng/mL |
Station |
Chemistry |
Synonym Name/Abbreviation |
CEA |
CPT Code |
82378 |
Performing Facility |
American Medical Labs, Herzliya |
Analyzer |
Roche cobas 6000 |
Test Method |
Electrochemiluminescence immunoassay (ECLIA) |
AML Preferred Tube |
5 mL SST gel |
Storage Instructions |
Refrigerated. Stability: 7 days 2 to 8 oC 6 months at -20oC ,Freeze only once. |
Min. Volume |
1 mL |
Turn-Around-Time |
One day |
Intended Use |
Immunoassay for the in vitro quantitative determination of carcinoembryonic antigen in human serum and plasma. This assay is further indicated for serial measurement of CEA to aid in the management of cancer patients. The main indication for CEA determinations is the follow-up and therapymanagement of colorectal carcinoma. The main indication for CEA determinations is the follow-up and therapymanagement of colorectal carcinoma. |
Limitations |
Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) |
Patient Preparation |
No patient preparation needed. |
Reasons for Rejection |
Do not use sodium citrate tube, Improper labeling. |
Adult Reference Ranges |
Non-smoker 0 – 3.4 ng/mL Smoker 0-5.2 ng/mL |